| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |